Heterogeneous stock rats: a model to study the genetics of despair‐like behavior in adolescence K Holl, H He, M Wedemeyer, L Clopton, S Wert, JK Meckes, R Cheng, ... Genes, Brain and Behavior 17 (2), 139-148, 2018 | 32 | 2018 |
Calcium-oligochitosan-pectin microcarrier for colonic drug delivery S Stealey, X Guo, R Majewski, A Dyble, K Lehman, M Wedemeyer, ... Pharmaceutical Development and Technology 25 (2), 260-265, 2020 | 24 | 2020 |
The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3 MJ Wedemeyer, SA Mahn, AE Getschman, KS Crawford, FC Peterson, ... Journal of Biological Chemistry 295 (40), 13927-13939, 2020 | 19 | 2020 |
Modeling the complete chemokine–receptor interaction MJ Wedemeyer, BK Mueller, BJ Bender, J Meiler, BF Volkman Methods in cell biology 149, 289-314, 2019 | 12 | 2019 |
Design of artificial red blood cells using polymeric hydrogel microcapsules: hydrogel stability improvement and polymer selection W Zhang, MJ Bissen, ES Savela, JN Clausen, SJ Fredricks, X Guo, ... The International journal of artificial organs 39 (10), 518-523, 2016 | 10 | 2016 |
The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist C Berg, MJ Wedemeyer, M Melynis, RR Schlimgen, LH Hansen, ... PLoS Pathogens 18 (3), e1010355, 2022 | 5 | 2022 |
Comparative modeling and docking of chemokine-receptor interactions with Rosetta MJ Wedemeyer, BK Mueller, BJ Bender, J Meiler, BF Volkman Biochemical and biophysical research communications 528 (2), 389-397, 2020 | 4 | 2020 |
Mechanistic insight into the suppression of polyglutamine aggregation by SRCP1 HN Haver, M Wedemeyer, E Butcher, FC Peterson, BF Volkman, ... ACS chemical biology 18 (3), 549-560, 2023 | 3 | 2023 |
14-3-3γ mediates the long-term inhibition of peripheral kappa opioid receptor antinociceptive signaling by norbinaltorphimine MJ Wedemeyer, EM Jennings, HR Smith, TS Chavera, RJ Jamshidi, ... Neuropharmacology 220, 109251, 2022 | 2 | 2022 |
Long-term Kappa Opioid Receptor Inhibition by Norbinaltorphimine and 14-3-3γ MJ Wedemeyer, E Jennings, HR Smith, T Chaver, R Jamshidi, K Berg, ... Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
Insurmountable Antagonism by Buprenorphine at Human Mu Opioid Receptors M Wedemeyer, K Berg, W Clarke Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
Characterization of Buprenorphine Antagonism at Human Mu Opioid Receptors MJ Wedemeyer, KA Berg, WP Clarke The FASEB Journal 36, 2022 | | 2022 |
Unraveling the Selectively Promiscuous Chemokine-Receptor Interaction Network MJ Wedemeyer The Medical College of Wisconsin, 2020 | | 2020 |
ENGINEERING ORTHOGONALITY INTO THE CHEMOKINE-GPCR INTERFACE USING ROSETTA M Wedemeyer, BK Mueller, J Meiler, B Volkman PROTEIN SCIENCE 28, 159-160, 2019 | | 2019 |
Heterogeneous Stock Rats: A Model To Study The Genetics Of Despair And Fluoxetine Resistance in Adolescence LCS Woods, K Holl, H He, M Wedemeyer, L Clopton, S Wert, J Meckes, ... The FASEB Journal 31, 1058.10-1058.10, 2017 | | 2017 |